Safety and Efficacy of NP-120 (Ifenprodil) for the Treatment of Hospitalized Patient With Confirmed COVID-19 Disease
Clinical trial NCT04382924 · COMPLETED
Trial details
- NCT number
- NCT04382924
- Sponsor
- Algernon Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-05
- Primary completion
- 2020-12-24
- Enrollment
- 168
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.